Gapping up
In reaction to earnings/guidance:
- AFRM +22.5%, AMRK +9.1%, PLAY +8.6%, IMOS +4.4%, ZS +2.9%, FIZZ +2.6%, ALB +2%, VRNT +1.1%, TSM +0.7%
Other news:
- ISEE +59.1% (in reaction to peer APLS study results)
- TTOO +24.6% (T2SARS-CoV-2 panel proves capable of detecting the Mu B.1.621 and Iota B.1.526 variants)
- ENDP +18.6% (settles opioid cases in New York)
- CBIO +12.8% (in reaction to peer APLS study results)
- CDR +8.5% (confirms initiation of dual-track review of strategic alternatives; also names new CFO)
- SANW +7.7% (INGR enters into stevia pilot production supply agreement with SANW)
- CORT +4% (to present results from Phase 2 trial of relacorilant)
- CTSO +3.8% (announced FDA Breakthrough Device Designation granted to DrugSorb-ATR)
- GOED +3.2% (Issues Statement Regarding Director Candidate Nominations From Kanen Wealth Management)
- OVV +2.8% (announces new capital allocation framework)
- PRCH +2.7% (acquires CSE Insurance and American Home Protect)
- DXLG +2.7% (prices offering of 5,733,076 shares of common stock by Red Mountain Partners at $6.10 per share)
- GLBE +2.2% (prices 12.0 mln share secondary offering at $64/share)
- WFC +2% (issues statement on OCC enforcement action)
- AVID +1.9% (authorizes $115 mln share repurchase program)
- OCDX +1.5% (prices secondary offering of 22 mln shares of common stock at $17.50 per share)
- ATAI +1.4% (ATAI announces usability study of Introspect's digital therapeutic app technology)
- UIHC +1.2% (provides estimated catastrophe losses for Q3)
- SE +1.2% (prices offering consisting of 11 mln ADSs at $318.00 per share and 2.5 bln of its 0.25% convertible senior notes due 2026)
- HELE +1% (announces new $500 mln share repurchase authorization)
- SPNE +1% (KIDS enters into distribution agreement with SPNE for 7D Surgical FLASH Navigation platform)
Analyst comments:
- EDIT +3.6% (upgraded to Outperform from Perform at Oppenheimer)
- ALLE +1.5% (upgraded to Buy from Neutral at Goldman)